ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 33 filers reported holding ELEDON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,035,000 | -1.0% | 375,000 | -12.5% | 0.00% | 0.0% |
| Q2 2022 | $1,045,000 | -52.3% | 428,360 | -22.9% | 0.00% | -55.6% |
| Q1 2022 | $2,190,000 | +15.1% | 555,895 | +28.8% | 0.01% | +12.5% |
| Q4 2021 | $1,903,000 | +46.9% | 431,435 | +105.9% | 0.01% | +33.3% |
| Q3 2021 | $1,295,000 | -13.3% | 209,490 | +11.0% | 0.01% | -14.3% |
| Q2 2021 | $1,493,000 | +11.6% | 188,690 | +51.0% | 0.01% | +16.7% |
| Q1 2021 | $1,338,000 | – | 125,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,339,793 | $10,598,000 | 0.89% |
| CM Management, LLC | 75,000 | $593,000 | 0.43% |
| Cormorant Asset Management, LP | 1,415,500 | $11,197,000 | 0.38% |
| BVF INC/IL | 1,113,435 | $8,807,000 | 0.33% |
| Ikarian Capital, LLC | 350,000 | $2,769,000 | 0.22% |
| Woodline Partners LP | 857,445 | $6,782,000 | 0.13% |
| INGALLS & SNYDER LLC | 51,149 | $405,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 853,208 | $6,749,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 40,052 | $317,000 | 0.01% |
| Point72 Asset Management, L.P. | 188,690 | $1,493,000 | 0.01% |